Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn

Table of Contents

June 01, 2008; Volume 73,Issue 6

Perspectives

  • You have access
    Making the T-Type Even Tinier: Corticotropin-Releasing Factor-Mediated Inhibition of Low-Voltage-Activated Calcium Channel Activity
    Diego L. Varela, Tamara Hermosilla and Gerald W. Zamponi
    Molecular Pharmacology June 2008, 73 (6) 1589-1591; DOI: https://doi.org/10.1124/mol.108.046961
  • You have access
    Refining Insights into High-Affinity Drug Binding to the Human Ether-à-go-go-Related Gene Potassium Channel
    Jules C. Hancox and Andrew F. James
    Molecular Pharmacology June 2008, 73 (6) 1592-1595; DOI: https://doi.org/10.1124/mol.108.047563

Articles

  • You have access
    Activation of Corticotropin-Releasing Factor Receptor 1 Selectively Inhibits CaV3.2 T-Type Calcium Channels
    Jin Tao, Michael E. Hildebrand, Ping Liao, Mui Cheng Liang, Gregory Tan, Shengnan Li, Terrance P. Snutch and Tuck Wah Soong
    Molecular Pharmacology June 2008, 73 (6) 1596-1609; DOI: https://doi.org/10.1124/mol.107.043612
  • You have access
    Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related (GITR)-Fc Fusion Protein Inhibits GITR Triggering and Protects from the Inflammatory Response after Spinal Cord Injury
    Giuseppe Nocentini, Salvatore Cuzzocrea, Tiziana Genovese, Rodolfo Bianchini, Emanuela Mazzon, Simona Ronchetti, Emanuela Esposito, Di Paola Rosanna, Placido Bramanti and Carlo Riccardi
    Molecular Pharmacology June 2008, 73 (6) 1610-1621; DOI: https://doi.org/10.1124/mol.107.044354
  • You have access
    Protease-Activated Receptor-1 Mediates Thrombin-Induced Persistent Sodium Current in Human Cardiomyocytes
    Caroline Pinet, Vincent Algalarrondo, Sylvie Sablayrolles, Bruno Le Grand, Christophe Pignier, Didier Cussac, Michel Perez, Stephane N. Hatem and Alain Coulombe
    Molecular Pharmacology June 2008, 73 (6) 1622-1631; DOI: https://doi.org/10.1124/mol.107.043182
  • You have access
    Combined Targeting of Epidermal Growth Factor Receptor, Signal Transducer and Activator of Transcription-3, and Bcl-XL Enhances Antitumor Effects in Squamous Cell Carcinoma of the Head and Neck
    Amanda L. Boehm, Malabika Sen, Raja Seethala, William E. Gooding, Maria Freilino, Silvia Man Yan Wong, Shaomeng Wang, Daniel E. Johnson and Jennifer Rubin Grandis
    Molecular Pharmacology June 2008, 73 (6) 1632-1642; DOI: https://doi.org/10.1124/mol.107.044636
  • You have access
    Topological Mapping of the Asymmetric Drug Binding to the Human Ether-à-go-go-Related Gene Product (HERG) Potassium Channel by Use of Tandem Dimers
    Toshihiko Myokai, Sunghi Ryu, Hirofumi Shimizu and Shigetoshi Oiki
    Molecular Pharmacology June 2008, 73 (6) 1643-1651; DOI: https://doi.org/10.1124/mol.107.042085
  • You have access
    The Nuclear Factor-κB Pathway Regulates Cytochrome P450 3A4 Protein Stability
    R. C. Zangar, N. Bollinger, S. Verma, N. J. Karin and Y. Lu
    Molecular Pharmacology June 2008, 73 (6) 1652-1658; DOI: https://doi.org/10.1124/mol.107.043976
  • You have access
    A Role for Leu118 of Loop E in Agonist Binding to the α7 Nicotinic Acetylcholine Receptor
    Shiva Amiri, Masaru Shimomura, Ranjit Vijayan, Hisashi Nishiwaki, Miki Akamatsu, Kazuhiko Matsuda, Andrew K. Jones, Mark S. P. Sansom, Philip C. Biggin and David B. Sattelle
    Molecular Pharmacology June 2008, 73 (6) 1659-1667; DOI: https://doi.org/10.1124/mol.107.041590
  • You have access
    Multipathway Model Enables Prediction of Kinase Inhibitor Cross-Talk Effects on Migration of Her2-Overexpressing Mammary Epithelial Cells
    Neil Kumar, Raffi Afeyan, Hyung-Do Kim and Douglas A. Lauffenburger
    Molecular Pharmacology June 2008, 73 (6) 1668-1678; DOI: https://doi.org/10.1124/mol.107.043794
  • You have access
    Inhibition of c-Myc Down-Regulation by Sustained Extracellular Signal-Regulated Kinase Activation Prevents the Antimetabolite Methotrexate- and Gemcitabine-Induced Differentiation in Non-Small-Cell Lung Cancer Cells
    Jordi M. Serra, Antonio Gutiérrez, Regina Alemany, María Navarro, Teresa Ros, Carlos Saus, Jordi Ginés, Antonia Sampol, Juan Carlos Amat, Lorenzo Serra-Moisés, Javier Martín, Antonio Galmés, Oliver Vögler and Joan Besalduch
    Molecular Pharmacology June 2008, 73 (6) 1679-1687; DOI: https://doi.org/10.1124/mol.107.043372
  • You have access
    A cAMP-Dependent, Protein Kinase A-Independent Signaling Pathway Mediating Neuritogenesis through Egr1 in PC12 Cells
    Aurélia Ravni, David Vaudry, Matthew J. Gerdin, Maribeth V. Eiden, Anthony Falluel-Morel, Bruno J. Gonzalez, Hubert Vaudry and Lee E. Eiden
    Molecular Pharmacology June 2008, 73 (6) 1688-1708; DOI: https://doi.org/10.1124/mol.107.044792
  • You have access
    Probing the Binding Sites and Mechanisms of Action of Two Human Ether-a-go-go-Related Gene Channel Activators, 1,3-bis-(2-Hydroxy-5-trifluoromethyl-phenyl)-urea (NS1643) and 2-[2-(3,4-Dichloro-phenyl)-2,3-dihydro-1H-isoindol-5-ylamino]-nicotinic acid (PD307243)
    Xulin Xu, Maurizio Recanatini, Marinella Roberti and Gea-Ny Tseng
    Molecular Pharmacology June 2008, 73 (6) 1709-1721; DOI: https://doi.org/10.1124/mol.108.045591
  • You have access
    Primary Peripheral T Cells Become Susceptible to 2,3,7,8-Tetrachlorodibenzo-p-Dioxin-Mediated Apoptosis in Vitro upon Activation and in the Presence of Dendritic Cells
    Narendra P. Singh, Mitzi Nagarkatti and Prakash Nagarkatti
    Molecular Pharmacology June 2008, 73 (6) 1722-1735; DOI: https://doi.org/10.1124/mol.107.043406
  • You have access
    Me-Talnetant and Osanetant Interact within Overlapping but Not Identical Binding Pockets in the Human Tachykinin Neurokinin 3 Receptor Transmembrane Domains
    Pari Malherbe, Caterina Bissantz, Anne Marcuz, Claudia Kratzeisen, Marie-Thérèse Zenner, Joseph G. Wettstein, Hasane Ratni, Claus Riemer and Will Spooren
    Molecular Pharmacology June 2008, 73 (6) 1736-1750; DOI: https://doi.org/10.1124/mol.107.042754
  • You have access
    Novel CYP2C9 Promoter Variants and Assessment of Their Impact on Gene Expression
    Melissa A. Kramer, Allan E. Rettie, Mark J. Rieder, Erwin T. Cabacungan and Ronald N. Hines
    Molecular Pharmacology June 2008, 73 (6) 1751-1760; DOI: https://doi.org/10.1124/mol.107.044149
  • You have access
    Identification of the Xenobiotic-Metabolizing Enzyme Arylamine N-Acetyltransferase 1 as a New Target of Cisplatin in Breast Cancer Cells: Molecular and Cellular Mechanisms of Inhibition
    Nilusha Ragunathan, Julien Dairou, Benjamin Pluvinage, Marta Martins, Emile Petit, Nathalie Janel, Jean-Marie Dupret and Fernando Rodrigues-Lima
    Molecular Pharmacology June 2008, 73 (6) 1761-1768; DOI: https://doi.org/10.1124/mol.108.045328
  • You have access
    Covalent Binding of the Nitroso Metabolite of Sulfamethoxazole Is Important in Induction of Drug-Specific T-Cell Responses in Vivo
    Linling Cheng, Benjamin J. Stewart, Qiang You, Dennis R. Petersen, Joseph A. Ware, Joseph R. Piccotti, Thomas T. Kawabata and Cynthia Ju
    Molecular Pharmacology June 2008, 73 (6) 1769-1775; DOI: https://doi.org/10.1124/mol.107.043273
  • You have access
    Potent, Selective and Cell Penetrant Inhibitors of SF-1 by Functional Ultra-High-Throughput Screening
    Franck Madoux, Xiaolin Li, Peter Chase, Gina Zastrow, Michael D. Cameron, Juliana J. Conkright, Patrick R. Griffin, Scott Thacher and Peter Hodder
    Molecular Pharmacology June 2008, 73 (6) 1776-1784; DOI: https://doi.org/10.1124/mol.108.045963
  • You have access
    Kavalactones Protect Neural Cells against Amyloid β Peptide-Induced Neurotoxicity via Extracellular Signal-Regulated Kinase 1/2-Dependent Nuclear Factor Erythroid 2-Related Factor 2 Activation
    Christoph J. Wruck, Mario E. Götz, Thomas Herdegen, Deike Varoga, Lars-Ove Brandenburg and Thomas Pufe
    Molecular Pharmacology June 2008, 73 (6) 1785-1795; DOI: https://doi.org/10.1124/mol.107.042499
  • You have access
    Partial Deletion of the Nicotinic Cholinergic Receptor α4 or β2 Subunit Genes Changes the Acetylcholine Sensitivity of Receptor-Mediated 86Rb+ Efflux in Cortex and Thalamus and Alters Relative Expression of α4 and β2 Subunits
    Cecilia Gotti, Milena Moretti, Natalie M. Meinerz, Francesco Clementi, Annalisa Gaimarri, Allan C. Collins and Michael J. Marks
    Molecular Pharmacology June 2008, 73 (6) 1796-1807; DOI: https://doi.org/10.1124/mol.108.045203
  • You have access
    Amiloride Derivatives and a Nonpeptidic Antagonist Bind at Two Distinct Allosteric Sites in the Human Gonadotropin-Releasing Hormone Receptor
    Laura H. Heitman, Kai Ye, Julia Oosterom and Adriaan P. IJzerman
    Molecular Pharmacology June 2008, 73 (6) 1808-1815; DOI: https://doi.org/10.1124/mol.107.043521
  • You have access
    Activation of Tyrosine Hydroxylase mRNA Translation by cAMP in Midbrain Dopaminergic Neurons
    Xiqun Chen, Lu Xu, Pheona Radcliffe, Baoyong Sun and A. William Tank
    Molecular Pharmacology June 2008, 73 (6) 1816-1828; DOI: https://doi.org/10.1124/mol.107.043968
  • You have access
    ATP Modulates Poly(ADP-Ribose) Polymerase-1-Facilitated Topoisomerase I-Linked DNA Religation in the Presence of Camptothecin
    Shin-Young Park, Chung-Hang Leung and Yung-Chi Cheng
    Molecular Pharmacology June 2008, 73 (6) 1829-1837; DOI: https://doi.org/10.1124/mol.107.044438
  • You have access
    Sazetidine-A Is a Potent and Selective Agonist at Native and Recombinant α4β2 Nicotinic Acetylcholine Receptors
    Ruud Zwart, Anna L. Carbone, Mirko Moroni, Isabel Bermudez, Adrian J. Mogg, Elizabeth A. Folly, Lisa M. Broad, Andrew C. Williams, Deyi Zhang, Chunjin Ding, Beverly A. Heinz and Emanuele Sher
    Molecular Pharmacology June 2008, 73 (6) 1838-1843; DOI: https://doi.org/10.1124/mol.108.045104
  • You have access
    Phenotype of the Cyp1a1/1a2/1b1(-/-) Triple-Knockout Mouse
    Nadine Dragin, Zhanquan Shi, Rajat Madan, Christopher L. Karp, Maureen A. Sartor, Chi Chen, Frank J. Gonzalez and Daniel W. Nebert
    Molecular Pharmacology June 2008, 73 (6) 1844-1856; DOI: https://doi.org/10.1124/mol.108.045658
  • You have access
    In Vivo Inhibition of Serine Protease Processing Requires a High Fractional Inhibition of Cathepsin C
    Nathalie Méthot, Daniel Guay, Joel Rubin, Diane Ethier, Karen Ortega, Simon Wong, Denis Normandin, Christian Beaulieu, T. Jagadeeswar Reddy, Denis Riendeau and M. David Percival
    Molecular Pharmacology June 2008, 73 (6) 1857-1865; DOI: https://doi.org/10.1124/mol.108.045682

Errata

  • You have access
    Correction to “α2 Subunit Specificity of Cyclothiazide Inhibition on Glycine Receptors”
    Molecular Pharmacology June 2008, 73 (6) 1866; DOI: https://doi.org/10.1124/mol.73.6.1866
  • You have access
    Correction to Table of Contents (Volume 73, Number 4, April 2008)
    Molecular Pharmacology June 2008, 73 (6) 1867; DOI: https://doi.org/10.1124/mol.73.6.1867
Back to top
PreviousNext

In this issue

Molecular Pharmacology: 73 (6)
Molecular Pharmacology
Vol. 73, Issue 6
1 Jun 2008
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Perspectives
  • Articles
  • Errata
  • Most Cited
  • Most Read
Loading
  • SB-431542 Is a Potent and Specific Inhibitor of Transforming Growth Factor-β Superfamily Type I Activin Receptor-Like Kinase (ALK) Receptors ALK4, ALK5, and ALK7
  • The G-Protein-Coupled Receptors in the Human Genome Form Five Main Families. Phylogenetic Analysis, Paralogon Groups, and Fingerprints
  • Pharmacological Properties of Y-27632, a Specific Inhibitor of Rho-Associated Kinases
  • Pharmacological characterization of five cloned voltage-gated K+ channels, types Kv1.1, 1.2, 1.3, 1.5, and 3.1, stably expressed in mammalian cell lines.
  • The Orphan Human Pregnane X Receptor Mediates the Transcriptional Activation of CYP3A4 by Rifampicin through a Distal Enhancer Module
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics